XPeng Inc. (XPEV)

Longboard Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 7, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	18,680	11,215	13,708	8,516	42,449	32,910
Market Cap Growth	172.50%	-18.19%	60.96%	-79.94%	28.99%	-
Enterprise Value	16,485	9,553	11,682	5,568	36,663	30,605
Last Close Price	19.62	11.82	14.59	9.94	50.33	42.83
PS Ratio	2.69	2.00	3.17	2.19	12.85	36.76
PB Ratio	4.40	2.62	2.68	1.59	6.40	6.24
P/TBV Ratio	5.90	3.43	3.40	1.77	6.63	6.40
P/OCF Ratio	-	-	101.66	-	-	-
EV/Sales Ratio	2.39	1.71	2.70	1.43	11.10	34.19
Debt / Equity Ratio	0.58	0.51	0.42	0.35	0.12	0.07
Asset Turnover	0.59	0.49	0.39	0.39	0.38	0.22
Inventory Turnover	7.02	6.29	6.00	6.61	9.15	6.14
Quick Ratio	0.89	0.95	1.21	1.52	2.41	4.38
Current Ratio	1.21	1.25	1.51	1.81	2.71	5.06
Return on Equity (ROE)	-15.45%	-17.13%	-28.33%	-23.12%	-12.70%	-14.31%
Return on Assets (ROA)	-4.34%	-5.06%	-8.70%	-7.91%	-7.56%	-9.80%
Return on Capital (ROIC)	-7.50%	-8.54%	-13.35%	-11.20%	-9.96%	-12.27%
Earnings Yield	-3.75%	-7.07%	-10.67%	-15.56%	-1.80%	-1.27%
FCF Yield	-	-5.18%	-1.70%	-21.30%	-1.27%	-0.44%
Buyback Yield / Dilution	-6.35%	-8.64%	-1.66%	-4.24%	-117.81%	-115.84%

Updated May 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q